Form Filed By MOTT DAVID M
Thu, Dec 10, 2020
Go to original document
ARDELYX, INC. (ARDX)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2020-12-10
Common Stock
Purchase
P
Type
Acquired 170,000 shares @ $5.89 per share
417,284 shares
Direct
Footnotes
1. This transaction was executed in multiple trades in prices ranging from $5.86 to $5.89, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
2. The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.